PLX - Protalix BioTherapeutics GAAP EPS of $0.00 misses by $0.03, revenue of $15.66M beats by $2.18M August, 14 2025 06:52 AM Protalix BioTherapeutics Inc. 2025-08-14 06:52:50 ET More on Protalix BioTherapeutics Protalix BioTherapeutics appoints Gilad Mamlok as CFO Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial information for Protalix BioTherapeutics For further details see: Protalix BioTherapeutics GAAP EPS of $0.00 misses by $0.03, revenue of $15.66M beats by $2.18M